LSTM Home > LSTM Research > LSTM Online Archive

High concentrations of membrane fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti

Hadlett, Max, Nagi, Sanjay, Sarkar, Manas, Paine, Mark ORCID: and Weetman, David ORCID: (2021) 'High concentrations of membrane fed ivermectin are required for substantial lethal and sublethal impacts on Aedes aegypti'. Parasites & Vectors, Vol 14, Issue 9.

s13071-020-04512-5.pdf - Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview


With widespread insecticide resistance in mosquito vectors, there is a pressing need to evaluate alternatives with different modes of action. Blood containing the antihelminthic drug ivermectin has been shown to have lethal and sub-lethal effects on mosquitoes. Almost all work to date has been on Anopheles spp., but impacts on other anthropophagic vectors could provide new options for their control, or additional value to anti-malarial ivermectin programmes.

Using dose-response assays delivered by membrane feeding, we evaluated the effects of ivermectin on daily mortality (up to 14-days post blood-feed) and fecundity of an Indian strain of Aedes aegypti.

The 7-day LC50 of ivermectin was calculated to be 178.6 ng/ml (95% CIs 142.3 – 218.4), much higher than recorded in all previous studies of Anopheles spp. In addition, significant effects on fecundity and egg hatch rates were only recorded at high ivermectin concentrations (≥ 250 ng/ul).

Our results suggest that levels present in human blood with current dosing regimes from mass drug administration or even a recent higher-dose antimalaria trial are unlikely to have a substantial impact on Ae. aegypti. Moreover, owing to the strong anthropophagy of Ae. aegypti, delivery of higher levels in livestock blood is also unlikely to be an effective option. However, other potential toxic impacts from ivermectin metabolites, accumulation in tissues, sublethal effects on behaviour, or antiviral action might increase the efficacy of ivermectin against Ae. aegypti and the arboviral diseases it transmits, and require further

Item Type: Article
Subjects: QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 256 Antimalarials
QX Parasitology > Insects. Other Parasites > QX 510 Mosquitoes
QX Parasitology > Insects. Other Parasites > QX 525 Aedes
Faculty: Department: Biological Sciences > Vector Biology Department
Digital Object Identifer (DOI):
Depositing User: Luciene Salas Jennings
Date Deposited: 12 Jan 2021 11:07
Last Modified: 12 Jan 2021 11:07


View details

Actions (login required)

Edit Item Edit Item